Pay in 4 interest-free payments of $7.01 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Glucagon-Like Peptide-1 Receptor Agonists and the Risk of Erectile Dysfunction: A Drug Target Mendelian Randomization Study
Li X, Kim SK, Nam KW, Kang JS, Choi HD, et al
For research & educational use only
Because retatrutide is not a licensed medicine in the UK, there is no official manufacturer's guidance, patient information leaflet, or standardised reconstitution protocol approved by the MHRA
17,18 Their mechanism of action involves the release of insulin, in the presence of elevated glucose concentrations, thus decreasing glucagon secretion
Contraindicated in MTC or MEN2 history Tirzepatide is not appropriate for patients with personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2
US$ 25.87
US$ 25.75
US$ 22.23
US$ 28.81
US$ 22.80
US$ 20.06
US$ 26.18
